Martingale Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-32,118
Closed -$479K 878
2022
Q1
$479K Sell
32,118
-27,750
-46% -$380K 0.01% 644
2021
Q4
$811K Sell
59,868
-3,415
-5% -$48.3K 0.01% 544
2021
Q3
$932K Sell
63,283
-48
-0.1% -$811 0.01% 523
2021
Q2
$1.15M Buy
63,331
+91
+0.1% +$1.62K 0.01% 366
2021
Q1
$1.1M Sell
63,240
-34,087
-35% -$599K 0.01% 398
2020
Q4
$1.69M Sell
97,327
-15,711
-14% -$251K 0.02% 314
2020
Q3
$1.56M Buy
113,038
+38,933
+53% +$572K 0.02% 494
2020
Q2
$1.07M Buy
74,105
+18,300
+33% +$241K 0.01% 714
2020
Q1
$610K Buy
+55,805
New +$1.03M 0.01% 780
2019
Q3
Sell
-10,003
Closed -$197K 1047
2019
Q2
$197K Buy
+10,003
New +$195K ﹤0.01% 991
2019
Q1
Sell
-40,608
Closed -$670K 1052
2018
Q4
$670K Sell
40,608
-1,800
-4% -$36.2K 0.01% 815
2018
Q3
$981K Buy
+42,408
New +$961K 0.01% 737

Other funds holding SBRA

Martingale Asset Management's SBRA Position: Q2 2022 in Review

Martingale Asset Management sold out of Sabra Healthcare REIT (SBRA) in Q2 2022, closing a stake of 32,118 shares — an estimated $479K sold.

Martingale Asset Management first reported a position in SBRA in Q3 2018 and held it in 12 quarters. The position peaked at $1.69M in Q4 2020. 332 funds tracked by Wall St. Rank hold SBRA as of Q2 2022.

  • Martingale Asset Management reported no remaining Sabra Healthcare REIT position as of Q2 2022 after selling out during the quarter.
  • Martingale Asset Management sold 32,118 Sabra Healthcare REIT shares in Q2 2022, an estimated $479K.
  • Martingale Asset Management first reported a position in Sabra Healthcare REIT in Q3 2018 and held it in 12 quarters.
  • Martingale Asset Management's Sabra Healthcare REIT position peaked at $1.69M in Q4 2020.
  • 332 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2022.

Based on Martingale Asset Management's 13F filing for Q2 2022, filed 11 Aug 2022.